Sector News

Lonza buys InterHealth in health push

August 15, 2016
Energy & Chemical Value Chain

Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Lonza said the California company’s range of products like UC-11 to promote healthy joints would complement its own in sports nutrition, weight management, immune and pet health.

“With this acquisition Lonza is taking a further step along our strategic path as a high-value supplier to the healthcare continuum,” Chief Executive Richard Ridinger said in a statement, adding that the deal also boosted Lonza’s offerings in cognitive and diabetes health.

The consultancy KPMG has forecast that the nutraceuticals market will be worth $280 billion in 2018, a factor that it expects will prompt a wave of mergers and acquisitions.

Swiss food giant Nestle is among companies that have shown an increasing interest in health foods, hiring a new CEO from German medical company Fresenius and investing in firms whose products are meant to restore a healthy bacterial balance in the gut.

GLOBAL ROLLOUT

Ridinger said Lonza would sell Interhealth’s products globally and use the U.S. company’s network to distribute the Swiss firm’s existing product range.

“Lonza has succeeded in making an important step in expanding its product portfolio into the attractive area of nutritional ingredients,” said Zuercher Kantonalbank analyst Philipp Gamper. “This area promises above average growth and good margins with less cyclical volatility.”

The Swiss company, which also makes products like drinking water sanitizers and preservatives for industrial applications, currently generates nearly 42 percent of its sales from pharmaceutical and biotech products.

But the nutraceuticals area is faster growing and more profitable than Lonza’s specialty ingredients business, which makes ingredients that go into consumer care products.

By John Revill

Source: Reuters

comments closed

Related News

June 22, 2024

Vynova announces R&D programme on PVC recycling technologies

Energy & Chemical Value Chain

Vynova announced the launch of a research & development programme to further advance PVC recycling and help the PVC value chain accelerate towards circularity. Vynova’s innovation efforts focus on technologies to remove heavy metals from dissolved rigid post-consumer PVC waste such as used window profiles or pipes.

June 22, 2024

Actylis appoints Scott Thomson as CEO

Energy & Chemical Value Chain

Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets formed in 2022, appointed Scott Thomson as new Chief Executive Officer. Scott Thomson, who succeeds Gilles Cottier at the helm of the Port Washington, NY-based CDMO, has a three-decade track record in the pharmaceutical and chemical industries.

June 22, 2024

ADM and Bayer expand regenerative agriculture partnership

Energy & Chemical Value Chain

ADM and Bayer have announced an extension of their regenerative agriculture collaboration, working with farmers to lower carbon emissions across Europe. The companies embarked on a feasibility study last year to evaluate regenerative agriculture practices’ impact on curbing carbon emissions, increasing biodiversity and improving soil health.

How can we help you?

We're easy to reach